MAPK8 and neuroblastoma: Using the neuroblastoma standard-of-care chemotherapy drug vincristine, we also observed that vorinostat priming of SH-SY5Y JNK-KTR cells significantly increased vincristine-induced JNK and caspase activation (Fig. 5A).